Open AccessP1634: EFFICACY AND SAFETY OF ELTROMBOPAG IN THE TREATMENT OF CHRONIC HEPATITIS B VIRUS INFECTION PATIENTS WITH THROMBOCYTOPENIA（HBV‐TP）: A PROSPECTIVE, MULTI‐CENTER, SINGLE ARM, PHASE II TRAIL
Author(s) -
Chen Y.,
Huang Y.,
Lai Y.,
Peng J.,
Zhou Z.,
Zhou H.,
Zhou R.,
Yang R.,
Zhang L.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000849392.16448.ae
Subject(s) - eltrombopag , medicine , gastroenterology , rituximab , clinical endpoint , cirrhosis , liver disease , chronic liver disease , immunology , platelet , randomized controlled trial , immune thrombocytopenia , lymphoma